Product Information
SUMATRIPTAN SUCC 100 MG TABLET is a generic product labeled by Bionpharma Inc., priced at $0.4341 per EA under NDC 69452034672. Its NADAC has been published 207 times since Jul 13, 2022.
The Low Outlier badge above means this manufacturer's average price in the Sumatriptan market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/1
Manufacturer
Bionpharma Inc.NDC
69452034672
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SUMATRIPTAN SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA078284On Market Since
2/18/2022
Pharmacological Classes
Price Statistics
The NADAC for SUMATRIPTAN SUCC 100 MG TABLET has been published 207 times since Jul 13, 2022, and over the history we have for it it has declined 17.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4341 per EA |
|---|---|
| All-time high | $0.5292 (Oct 12, 2022) |
| All-time low | $0.3720 (Nov 20, 2024) |
| 52-week high | $0.4721 |
| 52-week low | $0.4322 |
| Median price | $0.4707 |
| Average price | $0.4659 |
| Largest weekly change | -23.3% (Nov 20, 2024) |
| Weeks tracked | 207 |
| Tracking since | Jul 13, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SUMATRIPTAN SUCC 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SUMATRIPTAN SUCC 100 MG TABLET, manufactured by Bionpharma Inc., is $0.4341 per EA (NDC 69452034672), effective Jun 24, 2026.
How has the price of SUMATRIPTAN SUCC 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for SUMATRIPTAN SUCC 100 MG TABLET has declined 17.4%. It has been tracked across 207 weekly CMS publications since Jul 13, 2022.
What are the highest and lowest recorded NADAC prices for SUMATRIPTAN SUCC 100 MG TABLET?
Since Jul 13, 2022, the NADAC for SUMATRIPTAN SUCC 100 MG TABLET has ranged from a low of $0.3720 (Nov 20, 2024) to a high of $0.5292 (Oct 12, 2022), with a median of $0.4707 per EA.
Are there cheaper alternatives to SUMATRIPTAN SUCC 100 MG TABLET?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, SUMATRIPTAN SUCC 100 MG TABLET, is $0.4082 per EA — about 6% below SUMATRIPTAN SUCC 100 MG TABLET.
Who manufactures SUMATRIPTAN SUCC 100 MG TABLET?
SUMATRIPTAN SUCC 100 MG TABLET (NDC 69452034672) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification